subfoveal choroidal thickness before and after intravitreal Ranibizumab injection in patients with choroidal neovascularization
Background: Ranibizumab is anti-vascular endothelial growth factor (anti-VEGF) agent made for intraocular use, like smaller antibody fragment that can penetrate retina. Intravitreal ranibizumab therapy has been accepted as a predominant treatment for CNV in recent years. Objective: To assess potenti...
Na minha lista:
| Principais autores: | , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Al-Azhar University, Faculty of Medicine
2023-01-01
|
| 叢編: | Al-Azhar International Medical Journal |
| 主題: | |
| 在線閱讀: | https://aimj.journals.ekb.eg/article_473658_934df1eaa3fe56acb48118adb37229ab.pdf |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|